Have you ever wondered if there’s a way to move beyond the endless cycle of antiretroviral therapy (ART) for managing HIV? What if instead of just suppressing the virus, there was a treatment that could actually eliminate it?

That’s exactly what researchers are exploring with **CAR T-cell therapy**, and this isn’t just another theoretical experiment — it’s giving real hope to millions worldwide.

## Why CAR T-Cell Therapy Could Change the Game

Right now, over **38 million people** around the world live with HIV, relying on ART to keep the virus in check. While ART is effective, it’s a lifelong commitment that comes with side effects, adherence challenges, and no true cure. But what if there were another way?

A new clinical trial, funded by the **California Institute for Regenerative Medicine** and led by **Caring Cross** alongside **UC Davis Health**, is testing a radical new approach: **duoCAR T-cell therapy**. This treatment isn’t about managing HIV — it’s about potentially eliminating it.

## How CAR T-Cell Therapy Works

CAR T-cell therapy is an advanced form of **immunotherapy** that modifies your immune system to actively seek and destroy HIV-infected cells. Here’s how it works:

1. **T-Cell Collection** – Doctors extract **T-cells** (a type of immune cell) from the patient’s blood.
2. **Genetic Engineering** – These T-cells are modified in a lab by adding a **Chimeric Antigen Receptor (CAR)**, a special receptor designed to recognize and attack HIV-infected cells.
3. **Reintroduction into the Body** – The enhanced T-cells are then infused back into the patient, where they go to work, hunting down and destroying HIV-infected cells.

Unlike ART, which only **suppresses** HIV, **CAR T-cells might actually eliminate infected cells**, potentially reducing or even eliminating the need for daily medication.

### Why This Trial Is So Important

CAR T-cell therapy has already revolutionized **cancer treatment**, successfully treating **lymphomas and leukemias** where other therapies failed. Now, researchers are applying that same cutting-edge technology to HIV, hoping for a similar breakthrough.

This **first-in-human trial** is not just a lab experiment — it’s a **real-world test**. Participants in the trial have maintained an undetectable viral load for at least 12 months using ART. Now, researchers want to see if CAR T-cells can take over where ART leaves off.

## Inside the Trial: What’s Happening?

The trial is structured into three groups, each testing a different approach:

* **Cohort 1:** Receives a low dose of CAR T-cells. ART is stopped immediately after infusion.
* **Cohort 2:** Undergoes mild immune system conditioning with **cyclophosphamide** before receiving CAR T-cells. ART is stopped afterward.
* **Cohort 3:** Receives the same conditioning as Cohort 2 but with a **higher dose** of CAR T-cells.

Participants are closely monitored for **45 days**, with ART restarted if necessary to ensure safety.

## **Could CAR T-Cells Finally Beat HIV?**

The biggest challenge in curing HIV is its ability to **hide in “latent reservoirs”** within the body, waiting for the right moment to resurface. ART can’t reach these hidden cells, but **CAR T-cells can**.

Early **lab studies and animal models** have shown that CAR T-cell therapy can suppress HIV and even eliminate infected cells. Now, the first two participants have received the treatment, and **early results are promising** — no major side effects, and both individuals are doing well.

## What’s Next for CAR T-Cell Therapy?

The trial is still in its early stages, but here’s what to expect next:

1. **Expanding the Study** – If the initial results are positive, the trial will scale up to include more participants.
2. **Long-Term Monitoring** – Scientists will track how well CAR T-cells control HIV over months and years.
3. **Optimizing the Treatment** – Researchers will refine the therapy, making it more efficient and accessible.
4. **Regulatory Approval** – If successful, the therapy could move toward **FDA approval**, making it widely available.

## A Future Without HIV?

For decades, the dream of an **HIV cure** has felt just out of reach. But CAR T-cell therapy could change that. If this treatment works, it could mean a world where people with HIV no longer have to rely on daily ART and live in constant fear of viral rebound.

This isn’t just a scientific breakthrough — it’s a potential **turning point in global health**. A world without HIV might not be as far away as we once thought.

## **Source**

Connolly, L. (2023, April 19). Clinical trial begins using CAR T cells to potentially cure HIV. UC Davis Health. Retrieved from[ UC Davis Health](https://health.ucdavis.edu/news/headlines/clinical-trial-begins-using-car-t-cells-to-potentially-cure-hiv/2023/04).

Could CAR T-cell therapy cure HIV? This trial tests a breakthrough approach to eliminate the virus, offering hope beyond daily meds. Discover the future of HIV care.

No More Pills? How CAR T-Cell Therapy Could Free Millions from HIV

Could CAR T-cell therapy cure HIV? This trial tests a breakthrough approach to eliminate the virus, offering hope beyond daily meds. Discover the future of HIV 

No More Pills? How CAR T-Cell Therapy Could Free Millions from HIV

Popular Tags: